PR and some answers below... Todos Medical Esta
Post# of 1418
(Total Views: 195)
Posted On: 08/31/2022 2:33:21 PM
PR and some answers below...
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
August 31, 2022 09:11 ET
https://www.globenewswire.com/news-release/20...ction.html
Gerald Commissiong@G_Commish
$TOMDF - we’ve filed trademark for #TollovidComplete to cover next-gen formulation to include #Tollovid, CBD-A, Vitamin C and other key immune support ingredients. We’ll be expanding formulations including drinks and gummies in the future. We heard from parents who want options.
11:39 AM · Aug 31, 2022
Gerald Commissiong@G_Commish 1h
It’s not an investment really. We are cash positive out of the gate from CBD extraction and finished product white label. So from cash standpoint no drain, and it allows us to prepare for when we get that claim. Absolutely we expect demand to jump when the influencers kick in
Gerald Commissiong@G_Commish 1h
Hempori may distribute some of the products, but other than that for the time being no. Two separate companies. Ultimately that could change, but there are no plans now.
Gerald Commissiong@G_Commish 49m
We are aware. We will have multiple products and definitely are not stopping production of Tollovid standalone. With that said, we have strong reason to believe that the viral entry aspects, over a short period, can be helpful in getting people who don’t product nAb over the hump
Gerald Commissiong@G_Commish 35m
No problem. It’s understandable that this move isn’t immediately clear to everyone, but I think once you understand the botanicals market this makes a lot of sense. CBD market has nothing unique in it. Tollovid combo is easy sell to those buyers & mechanism of CBD-A complementary
Todos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A Production
August 31, 2022 09:11 ET
https://www.globenewswire.com/news-release/20...ction.html
Gerald Commissiong@G_Commish
$TOMDF - we’ve filed trademark for #TollovidComplete to cover next-gen formulation to include #Tollovid, CBD-A, Vitamin C and other key immune support ingredients. We’ll be expanding formulations including drinks and gummies in the future. We heard from parents who want options.
11:39 AM · Aug 31, 2022
Gerald Commissiong@G_Commish 1h
It’s not an investment really. We are cash positive out of the gate from CBD extraction and finished product white label. So from cash standpoint no drain, and it allows us to prepare for when we get that claim. Absolutely we expect demand to jump when the influencers kick in
Gerald Commissiong@G_Commish 1h
Hempori may distribute some of the products, but other than that for the time being no. Two separate companies. Ultimately that could change, but there are no plans now.
Gerald Commissiong@G_Commish 49m
We are aware. We will have multiple products and definitely are not stopping production of Tollovid standalone. With that said, we have strong reason to believe that the viral entry aspects, over a short period, can be helpful in getting people who don’t product nAb over the hump
Gerald Commissiong@G_Commish 35m
No problem. It’s understandable that this move isn’t immediately clear to everyone, but I think once you understand the botanicals market this makes a lot of sense. CBD market has nothing unique in it. Tollovid combo is easy sell to those buyers & mechanism of CBD-A complementary
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼